Biotechnology Assets [BST] vs Oryzon Genomics S.A [ORY] Detailed Stock Comparison

Biotechnology Assets

BME

Oryzon Genomics S.A

BME

TLDR: Quick Comparison Summary

Based on 18 vital metrics comparison: Biotechnology Assets wins in 4 metrics, Oryzon Genomics S.A wins in 13 metrics, with 0 ties. Oryzon Genomics S.A appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Biotechnology Assets	Oryzon Genomics S.A	Better
P/E Ratio (TTM)	10.77	-44.82	Oryzon Genomics S.A
Price-to-Book Ratio	3.56	1.79	Oryzon Genomics S.A
Debt-to-Equity Ratio	31.56	15.87	Oryzon Genomics S.A
PEG Ratio	-0.04	-15.53	Oryzon Genomics S.A
EV/EBITDA	-19.93	-38.99	Oryzon Genomics S.A
Profit Margin (TTM)	-98.39%	-56.48%	Oryzon Genomics S.A
Operating Margin (TTM)	-38.88%	6.30%	Oryzon Genomics S.A
EBITDA Margin (TTM)	N/A	6.30%	N/A
Return on Equity	-44.40%	-4.20%	Oryzon Genomics S.A
Return on Assets (TTM)	-9.11%	-2.52%	Oryzon Genomics S.A
Free Cash Flow (TTM)	$-794,574	$-16.15M	Biotechnology Assets
1-Year Return	16.13%	50.86%	Oryzon Genomics S.A
Price-to-Sales Ratio (TTM)	8.12	27.39	Biotechnology Assets
Enterprise Value	$25.77M	$191.64M	Oryzon Genomics S.A
EV/Revenue Ratio	8.69	25.65	Biotechnology Assets
Revenue per Share (TTM)	$0	$0	Oryzon Genomics S.A
Earnings per Share (Diluted)	$-0.04	$-0.06	Biotechnology Assets
Beta (Stock Volatility)	1.65	0.44	Oryzon Genomics S.A

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Biotechnology Assets vs Oryzon Genomics S.A Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Biotechnology Assets	-1.93%	2.86%	-12.20%	24.14%	0.00%	28.57%
Oryzon Genomics S.A	2.92%	1.15%	-8.01%	-2.22%	77.18%	76.00%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Biotechnology Assets	16.13%	89.47%	-53.85%	-88.75%	-84.07%	-84.07%
Oryzon Genomics S.A	50.86%	2.72%	-2.94%	-25.63%	-25.63%	-25.63%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Biotechnology Assets (BST): View Full Stock Overview

Oryzon Genomics S.A (ORY): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Biotechnology Assets vs Oryzon Genomics S.A

Metric	BST	ORY
Market Information
Market Cap i	€24.09M	€204.63M
Market Cap Category	Small cap	Mid cap
10 Day Avg. Volume i	155,262	393,818
90 Day Avg. Volume i	471,656	430,806
Last Close	€0.36	€2.64
52 Week Range	€0.24 - €0.49	€1.40 - €3.69
% from 52W High	-27.20%	-28.46%
All-Time High	€13.98 (Jun 23, 2014)	€5.25 (Dec 14, 2015)
% from All-Time High	-97.42%	-49.71%
Growth Metrics
Quarterly Revenue Growth	-0.18%	0.03%
Quarterly Earnings Growth	N/A	N/A
Financial Health
Profit Margin (TTM) i	-0.98%	-0.56%
Operating Margin (TTM) i	-0.39%	0.06%
Return on Equity (TTM) i	-0.44%	-0.04%
Debt to Equity (MRQ) i	31.56	15.87
Cash & Liquidity
Book Value per Share (MRQ)	€0.10	€1.47
Cash per Share (MRQ)	€0.00	€0.40
Operating Cash Flow (TTM) i	€-73,854	€-3,027,877
Levered Free Cash Flow (TTM) i	€347,742	€-10,217,728
Dividends
Last 12-Month Dividend Yield i	N/A	N/A
Last 12-Month Dividend i	N/A	N/A

Valuation & Enterprise Metrics Analysis: Biotechnology Assets vs Oryzon Genomics S.A

Metric	BST	ORY
Price Ratios
P/E Ratio (TTM) i	10.77	-44.82
Forward P/E i	N/A	-15.53
PEG Ratio i	-0.04	-15.53
Price to Sales (TTM) i	8.12	27.39
Price to Book (MRQ) i	3.56	1.79
Market Capitalization
Market Capitalization i	€24.09M	€204.63M
Enterprise Value i	€25.77M	€191.64M
Enterprise Value Metrics
Enterprise to Revenue i	8.69	25.65
Enterprise to EBITDA i	-19.93	-38.99
Risk & Other Metrics
Beta i	1.65	0.44
Book Value per Share (MRQ) i	€0.10	€1.47

Financial Statements Comparison: Biotechnology Assets vs Oryzon Genomics S.A

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	BST	ORY
Revenue/Sales i	N/A	€0
Cost of Goods Sold i	N/A	N/A
Gross Profit i	N/A	N/A
Research & Development i	N/A	€908,378
Operating Income (EBIT) i	N/A	€622,851
EBITDA i	N/A	€1.08M
Pre-Tax Income i	N/A	€-1.64M
Income Tax i	N/A	€-1.75M
Net Income (Profit) i	N/A	€117,803

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	BST	ORY
Cash & Equivalents i	€143,822	€36.04M
Total Current Assets i	€3.70M	€39.54M
Total Current Liabilities i	€4.55M	€15.07M
Long-Term Debt i	€2.39M	€5.85M
Total Shareholders Equity i	€6.61M	€132.30M
Retained Earnings i	€-23.57M	€-24.24M
Property, Plant & Equipment i	€481,199	€1.25M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	BST	ORY
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	BST	ORY
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	155,262	393,818
Average Daily Volume (90 Day) i	471,656	430,806
Shares Outstanding i	65.29M	64.75M
Float Shares i	N/A	61.07M
% Held by Insiders i	0.41%	0.21%
% Held by Institutions i	0.00%	0.04%

Dividend Analysis & Yield Comparison: Biotechnology Assets vs Oryzon Genomics S.A

Metric	BST	ORY
Last 12-Month Dividend i	N/A	N/A
Last 12-Month Dividend Yield i	N/A	N/A
3-Year Avg Annual Dividend i	N/A	N/A
3-Year Avg Dividend Yield i	N/A	N/A
3-Year Total Dividends i	N/A	N/A
Ex-Dividend Date	N/A	N/A

Biotechnology Assets [BST] vs Oryzon Genomics S.A [ORY] Detailed Stock Comparison